We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Sareum Announce Extension of Genentech Agreement
News

Sareum Announce Extension of Genentech Agreement

Sareum Announce Extension of Genentech Agreement
News

Sareum Announce Extension of Genentech Agreement

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Sareum Announce Extension of Genentech Agreement"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Sareum Holdings plc has announced that it has extended its agreement with Genentech, Inc. for a further 6 months following its initial agreement announced in November 2006.

Under the terms of this agreement, Sareum will continue to apply its skills in high throughput protein expression, purification and structure determination on drug discovery targets designated by Genentech.

In return, Sareum will receive research fees and may receive specific success-dependent milestone payments. Financial terms of the agreement were not disclosed.

Commenting on the agreement, Sareum’s Chief Executive Officer, Dr Tim Mitchell, said: “Successfully delivering on relationships with leading companies such as Genentech is a key component of our business strategy and an outstanding validation of Sareum’s technology and expertise. We are very pleased to have supported Genentech’s programs over the last 12 months, and look forward to continuing this important relationship.”

Advertisement